Vascular inflammatory markers in early-onset obese and type 2 diabetes subjects before and after three months' aerobic exercise training

Abstract

Early-onset type 2 diabetes (T2DM) may lead to very early vascular complications. Cardiovascular mortality is two to five times higher in adults with diabetes than in people without diabetes. The cardiovascular risk of young people with T2DM is unknown. T2DM in young people is associated with marked visceral obesity, insulin resistance and microalbuminuria. We recently showed that these subjects did not improve in either fitness (maximum volume of oxygen consumption, VO₂max) or glucose disposal after exercise training.

Seven subjects with early-onset T2DM (aged 26.1±0.9 years, body mass index [BMI] 35.6±1.2 kg/m²) and 14 age-matched obese subjects with normal glucose tolerance (aged 25. 6±0.9 years, BMI 34. 3±1.4 kg/m²) underwent aerobic training for 12 weeks. Serum vascular inflammatory markers (high-sensitivity C-reactive protein [hsCRP], soluble intercellular adhesion molecule [sICAM-1], soluble vascular cell adhesion molecule [sVCAM-1], E-Selectin and P-Selectin) were measured before and after the training programme.

At baseline, plasma concentrations of vascular inflammatory markers were significantly elevated in both groups. They did not improve after exercise.

Keywords

cardiovascular risk C-reactive protein E-Selectin exercise intercellular adhesion molecule obesity P-Selectin type 2 diabetes vascular inflammatory markers vascular cell adhesion molecule

References

1. Kannel WB , McGee DL. Diabetes and cardiovascular disease: the Framingham study. JAMA 1979;241:20035–8.

2. Fuller JH , Shipley MJ , Rose G , Jarrett RJ , Keen H. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall Study. BMJ 1983;287:867–70.

3. Stamler J , Vaccaro O , Neaton JD , Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434–44.

4. Barrett-Connor E , Cohn BA , Wingard DL , Edelstein SL. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA 1991;265:627–31.

5. Sicree R , Shaw JE , Zimmet PZ. Global and social implications of the diabetes epidemic. Nature 2001;414:782–7.

6. Alberti G , Zimmet P , Shaw J , Bloomgarden Z , Kaufman F , Silink M. Type 2 diabetes in the young: The evolving epidemic: International Diabetes Federation consensus workshop. Diabetes Care 2004;27:1798–811.

7. Mokdad AH , Ford ES , Bowman BA. et al. Diabetes trends in the US: 1990-1998. Diabetes Care 2000;23:1278–83.

8. Mokdad AH , Serdula MK , Dietz WH , Bowman BA , Marks JS , Koplan JP. The spread of the obesity epidemic in the United States, 1991-1998. JAMA 1999;181:1519–22.

9. McQuaid S , O'Gorman D , Yousif O. et al. Early onset insulin resistant diabetes in obese Caucasians has features of typical type 2 diabetes, but three decades earlier. Diabetes Care 2005;28:1216–18.

10.

10. Hatunic M , Burns N , Finucane F , Mannion C , Nolan JJ. Contrasting clinical and cardiovascular risk status between early and later onset Type 2 diabetes. Diabetes Vasc Dis Res 2005;2:73–5.

11.

11. Hillier TA , Pedula KL. Complications in young adults with early-onset type 2 diabetes. Diabetes Care 2003;26:2999–3005.

12.

12. Wei M , Kampert JB , Barlow CE. et al. Relationship between low cardiorespiratory fitness and mortality in normal-weight, over-weight, and obese men. JAMA 1999;282:1547–53.

13.

13. Haapanen- Niemi N , Miilunpalo S , Pasanen M. et al. Body mass index, physical inactivity and low level of physical fitness as determinants of all-cause and cardiovascular disease mortality − 16 years follow-up of middle aged and elderly men and women. Int J Obes Relat Metab Disord 2000;24:1401–04.

14.

14. Stevens J , Cai J , Evenson KR. et al. Fitness and fatness as predictors of mortality from all causes and cardiovascular disease in men and women in the lipid research clinical study. Am J Epidemiol 2002;156:832–41.

15.

15. Helmrich SP , Ragland DR , Leung RW , Paffenbarger RS Jr. Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med 1991;325:147–52.

16.

16. Knowler WC , Barrett-Connor E , Fowler SE. et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393–403.

17.

17. Pan XR , Li GW , Hu YH. et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997;20:537–44.

18.

18. Tuomilehto J , Lindstrom J , Eriksson JG. et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N EnglJ Med 2001;344:1343–50.

19.

19. DeFronzo RA , Sherwin RS , Kraemer N. Effect of physical training on insulin action in obesity. Diabetes 1987;36:1379–85.

20.

20. Hughes VA , Fiatarone MA , Fielding RA. et al. Exercise increases muscle GLUT-4 levels and insulin action in subjects with impaired glucose tolerance. Am J Physiol 1993;264:E855–E862.

21.

21. O'Gorman DJ , Karlsson H , McQuaid S. et al. Exercise training increases insulin-stimulated glucose disposal and GLUT-4 (SLC2A4) protein content in patients with Type 2 diabetes. Diabetologia 2006;49:2983–92.

22.

22. Burns N , Finucane FM , Hatunic M. et al. Early onset type 2 diabetes in obese Caucasians is characterised by a marked defect in beta-cell insulin secretion, severe insulin resistance and a lack of response to aerobic exercise training. Diabetologia 2007;50:1500–08.

23.

23. Haught WH , Mansour M , Rothlein R. et al. Alteration in circulating intercellular adhesion molecule-1 and L-selectine:further evidence for chronic inflammation in ischemic heart disease. Am Heart J 1996;132:1–8.

24.

24. Peter K , Nawroth P , Conradt C , Notdt T. et al. Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin and thrombomodulin. Arterioscler Thromb Vasc Biol 1997;17:505–12.

25.

25. Albertini JP , Valensi P , Lormeau B. et al. Soluble L-selectin level is a marker for coronary artery disease in type 2 diabetic patient. Diabetes Care 1999;22:2044–8.

26.

26. Rifai N , Ridker PM. High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin Chem 2001;47:403–11.

27.

27. Menshikova EV , Ritov VB , Ferrell RE , Azuma K , Goodpaster B , Kelley D. Characteristics of skeletal muscle mitochondrial biogenesis induced by moderate-intensity exercise and weight loss in obesity. J Appl Physiol 2007;103:21–7.

28.

28. Ridker PM , Rifai N , Pfeffer MA , Sacks F , Braunwald E. Long-term effects of pravastatin on plasma concentration of C-reactive protein: the Cholesterol and Recurrent Events (CARE) Investigators. Circulation 1999;100:230–5.